Management ChangeJul 27, 2026, 08:11 AM
Pitney Bowes Appoints La Vonda Williams to Board of Directors
AI Summary
Pitney Bowes Inc. announced the appointment of La Vonda Williams to its Board of Directors, effective July 21, 2026. Ms. Williams brings nearly 20 years of leadership experience in finance and operations, including executive roles at Onegevity Health and Goldman Sachs. She will serve on the Audit, Governance, and Strategic Review Committees, receiving an annual cash retainer of $200,000, additional committee retainers, and equity grants totaling $378,000 (prorated for her mid-year start).
Key Highlights
- La Vonda Williams appointed to Pitney Bowes Board of Directors on July 21, 2026.
- Ms. Williams assigned to the Audit Committee, Governance Committee, and Strategic Review Committee.
- Annual cash retainer of $200,000, plus $20,000 for Audit and $12,000 for Governance Committees.
- Annual equity grant of $100,000 (prorated to $81,095) in restricted stock units.
- Additional equity grant of $278,000 (prorated to $225,446) for Strategic Review Committee service.
- Ms. Williams is former CFO of Onegevity Health and VP of Equity Derivatives Operations at Goldman Sachs.
Price Impact
More from PBI